H.R. 10127 · 119th Congress · Health

TRANS Government Research Act

In committee485 words Introduced Aug 20, 2026 · Latest action Aug 20, 2026

How far it has goneStage 2 of 6
  1. IntroducedAug 20, 2026 Done
  2. CommitteeReferred to Energy and Commerce Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Full text

No CRS summary yet · 485 words

H.R. 10127 · Introduced in House · Aug 20, 2026

SECTION 1. SHORT TITLE.

This Act may be cited as the Terminating Radical Attempts to Negate Sex Through Government Research Act or the TRANS Government Research Act .

SEC. 2. PROHIBITION ON AVAILABILITY OF FEDERAL FUNDS FOR CERTAIN RESEARCH.

(a) In general. Notwithstanding any other provision of law, no Federal funds may be made available to directly or indirectly conduct, support, or fund covered research.

(b) Definitions. In this section: (1) Covered research The term covered research means research that studies the effects of— (A) gender-related medical treatment; or (B) any other means of altering the body or physical appearance of a person to no longer correspond to the sex of such person, including by— (i) disrupting the natural development of the body of such person; (ii) inhibiting the natural functions of the body of such person; and (iii) modifying the physical appearance or attire of such person. (2) Female The term female means an individual who, but for a developmental or genetic anomaly or historical accident, naturally has, had, will have, or would have a reproductive system that produces, transports, and utilizes eggs for fertilization. (3) Gender-related medical treatment The term gender-related medical treatment means— (A) with respect to an individual who is female, medical treatment provided for the purpose of addressing the perception of such individual that such individual is not female, including— (i) a surgical procedure, including— (I) a vaginectomy; (II) a hysterectomy; (III) an oophorectomy; (IV) the reconstruction of the urethra; (V) a metoidioplasty; (VI) a phalloplasty; (VII) a salpingo-oophorectomy; (VIII) a scrotoplasty; (IX) the implantation of erection or testicular protheses; (X) a subcutaneous mastectomy; (XI) vocal cord surgery; (XII) pectoral implantation; and (XIII) penile transplantation; (ii) an exogenous dose of testosterone or other androgen; and (iii) a puberty blocker, including— (I) a gonadotropin-releasing hormone (GnRH) agonist; and (II) a synthetic drug that— (aa) suppresses the production of estrogen and progesterone; or (bb) delays or suppresses pubertal development; and (B) with respect to an individual who is male, medical treatment provided for the purpose of addressing the perception of such individual that such individual is not male, including— (i) a surgical procedure, including— (I) a penectomy; (II) an orchiectomy; (III) a vaginoplasty; (IV) a clitoroplasty; (V) a vulvoplasty; (VI) an augmentation mammoplasty; (VII) facial feminization surgery; (VIII) vocal cord surgery; (IX) a chondrolaryngoplasty; (X) gluteal augmentation; and (XI) uterine transplantation; (ii) an exogenous dose of estrogen; and (iii) a puberty blocker, including— (I) a gonadotropin-releasing hormone (GnRH) agonist; and (II) a synthetic drug that— (aa) suppresses the production of testosterone; or (bb) delays or suppresses pubertal development. (4) Male The term male means an individual who, but for a developmental or genetic anomaly or historical accident, naturally has, had, will have, or would have a reproductive system that produces, transports, and utilizes sperm for fertilization. (5) Sex The term sex means the biological determination with respect to whether an individual is male or female.

Shown here because the text is under 500 words. Open on Congress.gov

Who lobbies on it

No lobbying filing on file names H.R. 10127.

Organizations that named H.R. 10127 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Aug 20, 2026Referred to the House Committee on Energy and Commerce.
  2. Aug 20, 2026Introduced in House

What members said about it

  • Statement · Press release · Sep 4, 2026 · Mace R-SC

    Congresswoman Nancy Mace Hits 100 Bills Introduced This Congress

    Leading South Carolina's entire Congressional delegation in bills introduced WASHINGTON, D.C., (Sept. 4, 2026) – Today, Congresswoman Nancy Mace (R-SC-01) marked a triple-digit milestone: 100 pieces of legislation introduced this Congress.

    “Reaching 100 bills is a huge milestone, but it's not the finish line.”